Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY:PLX)

1.700 +0.020 (+1.19%)
Streaming Delayed Price Updated: 9:50 AM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 70,095
Open 1.680
Bid (Size) 1.690 (8)
Ask (Size) 1.710 (22)
Prev. Close 1.680
Today's Range 1.675 - 1.710
52wk Range 0.8214 - 3.100
Shares Outstanding 73,633,583
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers in Friday's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill

Performance

YTD
-13.7%
-13.7%
1 Month
-33.3%
-33.3%
3 Month
-32.5%
-32.5%
6 Month
+2.4%
+2.4%
1 Year
+41.7%
+41.7%

More News

Read More
The market is filled with gapping stocks in Friday's session.
Via Chartmill
Earnings Outlook For Protalix BioTherapeutics
Via Benzinga
Earnings Preview: Protalix BioTherapeutics
Via Benzinga
Earnings Scheduled For November 6, 2023
Via Benzinga
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For May 9, 2025
Via Benzinga
Uncovering Potential: Protalix BioTherapeutics's Earnings Preview
Via Benzinga
Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead
Via Stocktwits
Topics Stocks
Exposures US Equities
Evaluating PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) using Mark Minervini’s winning stock formula
Via Chartmill
Does PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) show the characteristics of a Minervini super stock?
Via Chartmill
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Via ACCESS Newswire
Protalix BioTherapeutics Says With Debt Fully Repaid, It's Well-Positioned To Execute Strategy Through 2025 And Beyond
Via Benzinga
Earnings Scheduled For March 17, 2025
Via Benzinga
Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Earnings Scheduled For November 14, 2024
Via Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
From Virtual Investor Conferences
Via GlobeNewswire
PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 14, 2024
Via Benzinga
Pullix Gains Momentum As Gamestop Exits NFT Space
Via Talk Markets

Frequently Asked Questions

Is Protalix BioTherapeutics, Inc. (DE) Common Stock publicly traded?
Yes, Protalix BioTherapeutics, Inc. (DE) Common Stock is publicly traded.
What exchange does Protalix BioTherapeutics, Inc. (DE) Common Stock trade on?
Protalix BioTherapeutics, Inc. (DE) Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Protalix BioTherapeutics, Inc. (DE) Common Stock?
The ticker symbol for Protalix BioTherapeutics, Inc. (DE) Common Stock is PLX on the New York Stock Exchange
What is the current price of Protalix BioTherapeutics, Inc. (DE) Common Stock?
The current price of Protalix BioTherapeutics, Inc. (DE) Common Stock is 1.700
When was Protalix BioTherapeutics, Inc. (DE) Common Stock last traded?
The last trade of Protalix BioTherapeutics, Inc. (DE) Common Stock was at 05/20/25 09:50 AM ET
What is the market capitalization of Protalix BioTherapeutics, Inc. (DE) Common Stock?
The market capitalization of Protalix BioTherapeutics, Inc. (DE) Common Stock is 125.18M
How many shares of Protalix BioTherapeutics, Inc. (DE) Common Stock are outstanding?
Protalix BioTherapeutics, Inc. (DE) Common Stock has 125M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.